CHO/Human ROR1 Stable Cell Line Development Service

此产品为在研产品。如果您对此产品有兴趣,请直接联系我们。我们会根据您的需求相应地加速我们的研发进程,并为您进行产品预留。

货号-规格
价格
Qty.
SCCHO-ATP083-2Vials (1Vial X 2)
询价
Fiber-add-1piece
可选服务
询价
合计0件 产品金额¥ 0

产品信息

  1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
  2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
  3. Comprehensive application data to support assay development and validation
  4. Full tracible record, stringent quality control and validated cell passage stability
  5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
  6. Global commercial license assistance whenever regulatory filing is required

描述(Description)

CHO/Human ROR1 Stable Cell Line

应用说明(Application)

• Useful for cell-based ROR1 binding assay

生长特性(Growth Properties)

Adherent

筛选标记(Selection Marker)

Puromycin (2 μg/mL)

培养基(Complete Growth Medium)

F-12K + 10% FBS

冻存液(Freeze Medium)

Serum-free cell cryopreservation medium

装量(Quantity)

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

存储(Storage)

Frozen in liquid nitrogen.

使用说明(Instructions for Use)

See data sheet for detailed culturing and assay protocol.

产品数据图

 
 

产品评论
发表评论

背景

Tyrosine-protein kinase transmembrane receptor ROR1 is also known as Neurotrophic tyrosine kinase, receptor-related 1 (NTRKR1), which belongs to the protein kinase superfamily or tyr protein kinase family or ROR subfamily. ROR1 contains 1 FZ (frizzled) domain, 1 Ig-like C2-type (immunoglobulin-like) domain, 1 kringle domain, 1 protein kinase domain. ROR1 is expressed at high levels during early embryonic development. The expression levels drop strongly around day 16 and there are only very low levels in adult tissues. Isoform Short is strongly expressed in fetal and adult CNS and in a variety of human cancers, including those originating from CNS or PNS neuroectoderm. ROR1 could interact with casein kinase 1 epsilon (CK1ε) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth.

前沿进展

 
靶点信息
  • 英文全称:

    Inactive tyrosine-protein kinase transmembrane receptor ROR1

  • 中文全称:

    受体酪氨酸激酶样孤儿受体1

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    12 详情

  • 最高研发阶段:

    临床三期

数据表和文档
联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品信息
  • 产品数据图
  • 产品评论
  • 背景